Brief Report: SWOG S1400D (), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously-treated Patients with Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)

BACKGROUND: S1400D is a biomarker-driven therapeutic sub-study of Lung-MAP evaluating the fibroblast growth factor receptor (FGFR) inhibitor AZD4547 in patients with FGF pathway-activated squamous cell non-small cell lung cancer (SqNSCLC). This is the first phase II trial to evaluate AZD4547 as a ta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Oncol
Main Authors: Aggarwal, Charu, Redman, Mary W., Lara, Primo N., Borghaei, Hossein, Hoffman, Philip, Bradley, Jeffrey D., Newman, Alfred J., Feldman, Marvin J., Minichiello, Katherine, Miao, Jieling, Mack, Philip C., Papadimitrakopoulou, Vassiliki A., Herbst, Roy S., Kelly, Karen, Gandara, David R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6901020/
https://ncbi.nlm.nih.gov/pubmed/31195180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2019.05.041
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados